
TY  - JOUR
TI  - Abstracts
JO  - Vox Sanguinis
VL  - 74
IS  - S1
SN  - 0042-9007
UR  - https://doi.org/10.1111/j.1423-0410.1998.tb05472.x
DO  - doi:10.1111/j.1423-0410.1998.tb05472.x
SP  - 1
EP  - 191
PY  - 1998
ER  - 

TY  - JOUR
AU  - Yasukawa, Masaki
AU  - Fujiwara, Hiroshi
AU  - Ochi, Toshiki
AU  - Suemori, Koichiro
AU  - Narumi, Hiroshi
AU  - Azuma, Taichi
AU  - Kuzushima, Kiyotaka
TI  - Clinical efficacy of WT1 peptide vaccination in patients with acute myelogenous leukemia and myelodysplastic syndrome
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 84
IS  - 5
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.21387
DO  - doi:10.1002/ajh.21387
SP  - 314
EP  - 315
PY  - 2009
ER  - 

TY  - JOUR
AU  - Inamo, Jocelyn
AU  - Connes, Philippe
AU  - Barthélémy, Jean-Claude
AU  - Dan, Viorel
AU  - Coates, Thomas
AU  - Loko, Gylna
TI  - Pulmonary hypertension does not affect the autonomic nervous system dysfunction of sickle cell disease
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 84
IS  - 5
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.21377
DO  - doi:10.1002/ajh.21377
SP  - 311
EP  - 312
PY  - 2009
ER  - 

AU  - Renz, Nora
AU  - Trampuz, Andrej
C7  - pp. 23-36
TI  - Bone and Joint Infections
SN  - 9781119260318
UR  - https://doi.org/10.1002/9781119260363.ch3
DO  - doi:10.1002/9781119260363.ch3
SP  - 23-36
KW  - healthcare costs
KW  - musculoskeletal infections
KW  - osteomyelitis
KW  - prosthetic joint infection
KW  - septic arthritis
PY  - 2009
AB  - Summary The evidence base for diagnosis and management of musculoskeletal infections has become stronger in the last years with publication of a substantial number of new articles. This chapter covers three of the most important entities of musculoskeletal infection: septic arthritis, prosthetic joint infection (PJI), and osteomyelitis. It presents background, diagnosis, treatment and outcomes of septic arthritis, PJI and osteomyelitis. The chapter also presents some case examples. In native joints, septic arthritis is most commonly caused by hematogenous seeding of microorganisms from a distant infection focus. PJI represents an important complication, associated with high morbidity, need for complex treatment and substantial healthcare costs. Osteitis describes infection affecting only cortical bone; osteomyelitis implies that the cortex and medulla are involved. Osteomyelitis is classified by the route of infection. In contrast to acute osteomyelitis, chronic osteomyelitis and osteosynthesis-associated infections are unlikely to be eradicated without surgical treatment.
ER  - 

TY  - JOUR
AU  - Bloom, Chloe I.
AU  - Murphy, Kevin
AU  - Cummin, Andrew R.
TI  - Lung function tests in sickle cell patients
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 84
IS  - 5
SN  - 9781119260318
UR  - https://doi.org/10.1002/ajh.21378
DO  - doi:10.1002/ajh.21378
SP  - 310
EP  - 310
PY  - 2009
ER  - 

TY  - JOUR
AU  - Anoop, Parameswaran
AU  - Bevan, David H.
AU  - Chakrabarti, Suparno
TI  - Usefulness and limitations of Bayesian network model as a mortality risk assessment tool in sickle cell anemia
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 84
IS  - 5
SN  - 9781119260318
UR  - https://doi.org/10.1002/ajh.21379
DO  - doi:10.1002/ajh.21379
SP  - 312
EP  - 313
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts From the American Society for Apheresis 27th Annual Meeting, May 23-26, 2006 Las Vegas, Nevada
JO  - Journal of Clinical Apheresis
JA  - J. Clin. Apheresis
VL  - 21
IS  - 1
SN  - 9781119260318
UR  - https://doi.org/10.1002/jca.20098
DO  - doi:10.1002/jca.20098
SP  - 1
EP  - 48
PY  - 2006
ER  - 

AU  - Amodio, Piero
C7  - pp. 105-123
TI  - Hepatic encephalopathy
SN  - 9781118274828
UR  - https://doi.org/10.1002/9781118412640.ch11
DO  - doi:10.1002/9781118412640.ch11
SP  - 105-123
KW  - psychometric tests
KW  - EEG
KW  - rifaximine
KW  - lactulose
KW  - probiotics
KW  - ammonia
KW  - branched chain amino acids
KW  - L-ornithine-L-aspartate
KW  - ornitine-phenylacetate
KW  - glycerol-phenylbutyrate
PY  - 2006
AB  - Summary Hepatic encephalopathy (HE) has relevant consequences on the quality of life of patients and their caregivers, and is one of the principal causes of hospitalization in cirrhosis. Also, HE is a marker of poor prognosis. Its diagnosis requires an accurate and work-up to consider confounders, factors of vulnerability, and precipitation. The detection and monitoring of the covert expression of HE, which require psychometric or neurophysiologic investigation having their own specific characteristics and value, is considered in detail. Understanding the pathophysiologic mechanisms underlying this condition, treatment options are highlighted in their meaning, so that clinical practice is greatly helped by this comprehensive update.
ER  - 

TY  - JOUR
TI  - Scientific
JO  - Transfusion
VL  - 47
IS  - s3
SN  - 9781118274828
UR  - https://doi.org/10.1111/j.1537-2995.2007.01507_1.x
DO  - doi:10.1111/j.1537-2995.2007.01507_1.x
SP  - 1A
EP  - 216A
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts of Papers to be Presented at American Association of Blood Banks. 49 Annual Meeting October 12–16, 1996
JO  - Transfusion
VL  - 36
IS  - S9
SN  - 9781118274828
UR  - https://doi.org/10.1111/j.1537-2995.1996.tb02719.x
DO  - doi:10.1111/j.1537-2995.1996.tb02719.x
SP  - 1s
EP  - 65s
PY  - 1996
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - BJU International
JA  - BJU Int
VL  - 120
IS  - S2
SN  - 9781118274828
UR  - https://doi.org/10.1111/bju.13951
DO  - doi:10.1111/bju.13951
SP  - 24
EP  - 51
PY  - 2017
ER  - 

TY  - JOUR
AU  - Simak, Jan
AU  - De Paoli, Silvia
C7  - e1448
TI  - The effects of nanomaterials on blood coagulation in hemostasis and thrombosis
JO  - WIREs Nanomedicine and Nanobiotechnology
JA  - WIREs Nanomed Nanobiotechnol
VL  - 9
IS  - 5
SN  - 9781118274828
UR  - https://doi.org/10.1002/wnan.1448
DO  - doi:10.1002/wnan.1448
SP  - e1448
PY  - 2017
AB  - The blood coagulation balance in the organism is achieved by the interaction of the blood platelets (PLTs) with the plasma coagulation system (PCS) and the vascular endothelial cells. In healthy organism, these systems prevent thrombosis and, in events of vascular damage, enable blood clotting to stop bleeding. The dysregulation of hemostasis may cause serious thrombotic and/or hemorrhagic pathologies. Numerous engineered nanomaterials are being investigated for biomedical purposes and are unavoidably exposed to the blood. Also, nanomaterials may access vascular system after occupational, environmental, or other types of exposure. Thus, it is essential to evaluate the effects of engineered nanomaterials on hemostasis. This review focuses on investigations of nanomaterial interactions with the blood components involved in blood coagulation: the PCS and PLTs. Particular emphases include the pathophysiology of effects of nanomaterials on the PCS, including the kallikrein-kinin system, and on PLTs. Methods for investigating these interactions are briefly described, and a review of the most important studies on the interactions of nanomaterials with plasma coagulation and platelets is provided. WIREs Nanomed Nanobiotechnol 2017, 9:e1448. doi: 10.1002/wnan.1448 This article is categorized under: Implantable Materials and Surgical Technologies > Nanomaterials and Implants Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials
ER  - 

C7  - pp. 157-215
TI  - Charcot Case Studies
SN  - 9780470998236
UR  - https://doi.org/10.1002/9780470682944.ch3
DO  - doi:10.1002/9780470682944.ch3
SP  - 157-215
KW  - Charcot Case Studies
KW  - Charcot Restraint Orthotic Walker (CROW)
KW  - bone mineral density (BMD)
KW  - “like egg shells”
KW  - “uncomfortable numbness”
KW  - “walked a lot and run for a bus”
KW  - Different presentations
KW  - Conservative care
PY  - 2017
AB  - Summary This chapter contains sections titled: Introduction Early diagnosis Different presentations Surgery Conservative care
ER  - 

TY  - JOUR
AU  - Messer, Jeannette S.
AU  - Kegge, Samantha J.
AU  - Cooper, Edward S.
AU  - Colitz, Carmen M.H.
AU  - Abramson, Carley J.
TI  - Meningoencephalomyelitis Caused by Pasteurella multocida in a Cat
JO  - Journal of Veterinary Internal Medicine
VL  - 20
IS  - 4
SN  - 9780470998236
UR  - https://doi.org/10.1111/j.1939-1676.2006.tb01825.x
DO  - doi:10.1111/j.1939-1676.2006.tb01825.x
SP  - 1033
EP  - 1036
PY  - 2006
ER  - 

TY  - JOUR
AU  - Cash, Jenna L
AU  - Bena, Stefania
AU  - Headland, Sarah E
AU  - McArthur, Simon
AU  - Brancaleone, Vincenzo
AU  - Perretti, Mauro
TI  - Chemerin15 inhibits neutrophil-mediated vascular inflammation and myocardial ischemia-reperfusion injury through ChemR23
JO  - EMBO reports
VL  - 14
IS  - 11
SN  - 9780470998236
UR  - https://doi.org/10.1038/embor.2013.138
DO  - doi:10.1038/embor.2013.138
SP  - 999
EP  - 1007
KW  - chemerin peptide
KW  - inflammation
KW  - intravital microscopy
KW  - neutrophil
KW  - resolution
PY  - 2013
AB  - Neutrophil activation and adhesion must be tightly controlled to prevent complications associated with excessive inflammatory responses. The role of the anti-inflammatory peptide chemerin15 (C15) and the receptor ChemR23 in neutrophil physiology is unknown. Here, we report that ChemR23 is expressed in neutrophil granules and rapidly upregulated upon neutrophil activation. C15 inhibits integrin activation and clustering, reducing neutrophil adhesion and chemotaxis in vitro. In the inflamed microvasculature, C15 rapidly modulates neutrophil physiology inducing adherent cell detachment from the inflamed endothelium, while reducing neutrophil recruitment and heart damage in a murine myocardial infarction model. These effects are mediated through ChemR23. We identify the C15/ChemR23 pathway as a new regulator and thus therapeutic target in neutrophil-driven pathologies.
ER  - 

TY  - JOUR
TI  - Paper Abstract
JO  - Journal of the American Geriatrics Society
JA  - J Am Geriatr Soc
VL  - 66
IS  - S2
SN  - 9780470998236
UR  - https://doi.org/10.1111/jgs.15376
DO  - doi:10.1111/jgs.15376
SP  - S1
EP  - S369
PY  - 2018
ER  - 

TY  - JOUR
TI  - Oral and Poster Presentations
JO  - Catheterization and Cardiovascular Interventions
JA  - Cathet. Cardiovasc. Intervent.
VL  - 79
IS  - S1
SN  - 9780470998236
UR  - https://doi.org/10.1002/ccd.24386
DO  - doi:10.1002/ccd.24386
SP  - S1
EP  - S110
PY  - 2012
ER  - 

TY  - JOUR
AU  - Ruiz-Argüelles, Guillermo J.
AU  - Lobato-Mendizábal, Eduardo
AU  - Delgado-Lamas, José Luis
AU  - Gómez-Almaguer, David
TI  - All trans-retinoic acid decreases early mortality in patients with promyelocytic leukemia and can be given entirely on an outpatient basis
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 62
IS  - 3
SN  - 9780470998236
UR  - https://doi.org/10.1002/(SICI)1096-8652(199911)62:3<139::AID-AJH2>3.0.CO;2-F
DO  - doi:10.1002/(SICI)1096-8652(199911)62:3<139::AID-AJH2>3.0.CO;2-F
SP  - 139
EP  - 143
KW  - leukemia
KW  - promyelocytic
KW  - ATRA
KW  - mortality
KW  - outpatient
PY  - 1999
AB  - Abstract The results of the treatment of 43 patients with acute promyelocytic leukemia (PML) are reported: 27 were treated initially with all-trans-retinoic acid (ATRA), whereas 16 were treated with conventional chemotherapy. All patients received myelosuppressive chemotherapy after the initial treatment. Respectively, the complete remission rate was 92% and 37% (P < 0.01), the 5-day mortality rate was 0% and 44% (P < 0.001), and the 28-day mortality rate was 4% and 44% (P < 0.001). The median disease-free survival was 12 and 1 months (P < 0.01), whereas the 12-month disease-free survival was 50% and 13% (P < 0.01) and the 36-month disease-free survival was 41% and 9% (P < 0.01). Thirteen of the patients treated with ATRA were given the treatment fully as outpatients. ATRA given as initial therapy decreased significantly early mortality in promyelocytic leukemia patients; because some promyelocytic leukemia patients given ATRA as initial therapy can be treated as outpatients, the costs of this treatment modality may be diminished. Am. J. Hematol. 62:139?143, 1999. ? 1999 Wiley-Liss, Inc.
ER  - 

TY  - JOUR
TI  - ABSTRACTS OF SUBMISSIONS ACCEPTED FOR PRESENTATIOIN
JO  - Journal of General Internal Medicine
VL  - 20
IS  - S1
SN  - 9780470998236
UR  - https://doi.org/10.1111/j.1525-1497.2005.020S1.x
DO  - doi:10.1111/j.1525-1497.2005.020S1.x
SP  - 25
EP  - 279
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Vox Sanguinis
JA  - Vox Sang
VL  - 105
IS  - s1
SN  - 9780470998236
UR  - https://doi.org/10.1111/vox.12048
DO  - doi:10.1111/vox.12048
SP  - 65
EP  - 299
PY  - 2013
ER  - 
